hat
IV Fosaprepitant 115 mg nan jou 1 sèlman kòm yon perfusion sou minit 15, minit 30 anvan chimyoterapi. Apwopriye 80 mg aloral ta dwe administre nan jou 2 ak 3. Apapitant 125 mg oralman ka ranplase pou fosaprepitant 115 mg IV nan jou 1. Administre nan konjonksyon avèk yon kortikoterapi (dexamethasone 12 mg oralman minit 30 anvan chimyoterapi jou 1 ak 8 mg oralman nan maten an nan jou 2 jiska 4) ak yon 5-HT antagonist 3 (ondansetron 32 mg IV minit 30 anvan chimyoterapi sou jou 1).
eng
IV Fosaprepitant 115 mg on day 1 only as an infusion over 15 minutes, 30 minutes prior to chemotherapy. Aprepitant 80 mg orally should be administered on days 2 and 3. Aprepitant 125 mg orally may be substituted for fosaprepitant 115 mg IV on day 1. Administer in conjunction with a corticosteroid (dexamethasone 12 mg orally 30 minutes prior to chemotherapy on day 1 and 8 mg orally in the morning on days 2 through 4) and a 5-HT 3 antagonist (ondansetron 32 mg IV 30 minutes prior to chemotherapy on day 1).